MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers - Contacts and Locations

Home

MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

This study has been completed.

Study NCT00563433. Last updated on November 21, 2007. Information provided by MacroChem Corporation

Please refer to this study by its ClinicalTrials.gov identifier: NCT00563433

Locations


United States, Washington
	Seattle VA Medical Center
	Seattle, Washington, United States, 98108-1597

Sponsors and Collaborators

MacroChem Corporation

Genaera Corporation

Investigators


Study Director:	Paul Litka, MD	Magainin Pharmaceuticals, Inc.